Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery

Antithrombotic Therapy for VTE Disease

Clive Kearon, Elie A. Akl, Joseph Ornelas et al. · CHEST Journal · 2016 · 4.8K citations

Medicine, Hematology, Pharmacotherapy +12

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

Gillian D Sanders, Peter J. Neumann, Anirban Basu et al. · JAMA · 2016 · 3K citations · Full text

Pharmacy, Health Administration, Health Policy +17

Executive Summary

Gordon Guyatt, Elie A. Akl, Mark Crowther et al. · CHEST Journal · 2012 · 1.5K citations · Full text

Education, Elementary Education, Instruction +16

Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer

David Bergqvist, Giancarlo Agnelli, Alexander T. Cohen et al. · New England Journal of Medicine · 2002 · 1K citations · Full text

Medicine, Perioperative Medicine, Surgery +11

Thresholds for the cost–effectiveness of interventions: alternative approaches

Elliot Marseille, Bruce A. Larson, Dhruv S. Kazi et al. · Bulletin of the World Health Organization · 2014 · 873 citations · Full text

Pharmacy, Economics, Health Policy +15